文献速递腹部泌尿生殖介入CTDSA

对比增强计算机断层扫描后72小时内行内镜逆行胰胆管造影与对比剂肾毒性的关联

Association between contrast-induced nephrotoxicity and contrast enhanced computed tomography followed by endoscopic retrograde cholangiopancreatography.
PubMed 文献 · Eur J Radiol · 2020-05-19

该单中心回顾性队列研究纳入2016年10月1日至2019年6月30日急诊科因腹部症状行对比增强计算机断层扫描(CECT)的连续成人患者1457例,其中90例(6.2%)在CECT后72小时内行内镜逆行胰胆管造影(ERCP),93例(6.4%)发生对比剂肾毒性(CIN)。多因素分析显示,CECT后72小时内行ERCP(OR 3.31,95%CI 1.74–6.29,p<0.001)和CECT前血清肌酐>1.5 mg/dL(OR 9.86,95%CI 5.08–19.2,p<0.001)是CIN的独立危险因素;93例CIN患者中10例(11%)为持续性CIN,3个月时间范围内未发现与持续性CIN相关的特定因素。

要点

  • CECT后72小时内行ERCP与CIN风险升高独立相关(OR 3.31)。
  • CECT前血清肌酐>1.5 mg/dL是CIN的强独立危险因素(OR 9.86)。
  • 93例CIN患者中11%为持续性CIN,未发现相关特定因素。

核心结论

  • CECT后72小时内行ERCP及CECT前血清肌酐>1.5 mg/dL与CIN发生相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入2016年10月1日至2019年6月30日急诊科因腹部症状行CECT的连续成人患者1457例。
  • CIN定义为CECT后72小时内血清肌酐>0.5 mg/dL或较CECT前升高>25%。
  • 采用逻辑回归分析年龄、性别、体重指数、合并症、用药、CECT前血清肌酐>1.5 mg/dL及CECT后72小时内行ERCP等变量。
  • 持续性CIN于最早3个月后获取血清肌酐,并与ERCP和CECT后72小时内数据比较。

诊断标准与关键数值

  • CIN诊断标准:CECT后72小时内血清肌酐>0.5 mg/dL或较CECT前升高>25%。
  • CECT后72小时内行ERCP的CIN风险OR 3.31(95%CI 1.74–6.29,p<0.001)。
  • CECT前血清肌酐>1.5 mg/dL的CIN风险OR 9.86(95%CI 5.08–19.2,p<0.001)。
  • 1457例中90例(6.2%)在CECT后72小时内行ERCP,93例(6.4%)发生CIN。
  • 93例CIN患者中10例(11%)为持续性CIN。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine if endoscopic retrograde cholangiopancreatography (ERCP) performed within 72 h after contrast enhanced computed tomography (CECT) increases contrast-induced nephrotoxicity (CIN) risk in patients with abdominal complaints.

METHOD: This single-center retrospective cohort study included consecutive adult patients with abdominal complaints who underwent CECT between October 1, 2016, and June 30, 2019 at an emergency department (ED). CIN was diagnosed based on serum creatinine (SCr) level >0.5 mg/dL within 72 h after CECT or that increased >25 % compared to pre-CECT level. Logistic regression analysis was performed to determine independent risk factors for CIN, including age, sex, body mass index, comorbidities, medication, pre-CECT SCr level >1.5 mg/dL, and ERCP performed within 72 h after CECT. For persistent CIN, SCr level was obtained after 3 months at the earliest and compared to data obtained within 72 h after ERCP and CECT.

RESULTS: Of 1457 patients with CECT, 90 (6.2 %) underwent ERCP within 72 h after CECT and 93 (6.4 %) developed CIN. Multivariate analysis revealed that ERCP performed within 72 h after CECT (odds ratio, 3.31; 95 % confidence interval, 1.74, 6.29; p < 0.001) and pre-CECT SCr level >1.5 mg/dL (odds ratio, 9.86; 95 % confidence interval, 5.08, 19.2; p < 0.001) were independent risk factors for CIN. Of 93 patients with CIN, 10 (11 %) had persistent CIN. No specific factors were correlated with persistent CIN in the 3-month time frame.

CONCLUSION: ERCP performed within 72 h after CECT and pre-CECT SCr level >1.5 mg/dL are associated with CIN development.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Shinoura S, Tokushige A, Chinen K, et al. Association between contrast-induced nephrotoxicity and contrast enhanced computed tomography followed by endoscopic retrograde cholangiopancreatography. Eur J Radiol. 2020. PMID: 32473539. doi:10.1016/j.ejrad.2020.109074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。